In drug-naïve patients with MDD, EMP1 levels were significantly lower when compared with controls and, after 8 weeks of antidepressant treatment, EMP1 mRNA levels showed a trend towards an increase [ 60 ].
← all excerpts
Depression pathogenesis and treatment: what can we learn from blood mRNA expression?
1
—
—